Florham Park, NJ, United States of America

Steven Gregory Mischke

This inventor holds 29 USPTO granted patents and 8 published patent applications and 10 EPO patents, primarily in Ubiquitin-Proteasome Inhibition. Top assignees: Hoffmann-La Roche Inc., Forma Therapeutics, Inc., Valo Early Discovery, Inc.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Gregory Mischke. Retrieved from https://idiyas.com/inventor/steven-gregory-mischke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 8)

% Patents Active = 58.6

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 61(Granted Patents)

Location History:

Florham Park, NJ (US) (2000 - 2017)
Waltham, MA (US) (2016 - 2023)

Company Filing History:

15 out of 5,027

Hoffmann-La Roche Inc.

patents

9 out of 125

Forma Therapeutics, Inc.

patents

2 out of 15

Valo Early Discovery, Inc.

Takeda Pharmaceutical Company Limited

patents

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

CREB Binding Protein

Ubiquitin-Specific Protease

GFAT Inhibitors

Thienopyrazine

Pyrrolines

Azaheterocycles

Antiproliferative Compounds

Dimeric Compounds

Thiazolyl-Benzimidazoles

Halo-Substituted Pyrimidodiazepines

MCH Receptor Antagonists

Substituted Piperidines

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12378242 - Inhibiting CREB binding protein (CBP) (2025-08-05),

2. 12351577 - Inhibiting cyclic AMP-responsive element-binding protein (CREB) (2025-07-08),

3. 12252490 - Inhibiting deubiquitinase USP25 and USP28 (2025-03-18),

4. 11814386 - Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors (2023-11-14),

5. 11787803 - Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors (2023-10-17),

6. 11535618 - Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors (2022-12-27),

7. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2022-05-10),

8. 11292791 - Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors (2022-04-05),

9. 11254674 - Inhibiting CREB binding protein (CBP) (2022-02-22),

10. 11247987 - Inhibiting ubiquitin specific peptidase 30 (2022-02-15),

11. 10913753 - Thienopyridine carboxamides as ubiquitin-specific protease inhibitors (2021-02-09),

12. 10889592 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors (2021-01-12),

13. 10870648 - Inhibiting CREB binding protein (CBP) (2020-12-22),

14. 9611224 - Antiproliferative benzo [B] azepin-2-ones (2017-04-04),

15. 9422332 - Azaheterocycles as BIR2 and/or BIR3 inhibitors (2016-08-23),

Title: The Innovative Journey of Steven Gregory Mischke

Introduction: Steven Gregory Mischke, a talented inventor hailing from Florham Park, NJ (US), has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Steven Gregory Mischke holds several patents in various fields, including technology, engineering, and healthcare. His recent patents focus on cutting-edge solutions for everyday challenges, showcasing his commitment to pushing the boundaries of innovation.

Career Highlights: Throughout his illustrious career, Steven Gregory Mischke has been recognized for his groundbreaking inventions that have revolutionized industries. His ability to think outside the box and translate ideas into tangible products has set him apart as a visionary inventor.

Collaborations: Steven Gregory Mischke has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His partnerships have been instrumental in turning his innovative concepts into reality, further solidifying his reputation as a prolific inventor.

Conclusion: Steven Gregory Mischke's passion for innovation and relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire future generations of inventors to think boldly and create solutions that shape the world we live in.

Profile summary based on public USPTO records.